a prospective controlled trial on the use of 1 month 's antimicrobial therapy in patients with relapse of crohn 's disease revealed that metronidazole was associated with a 57 % response rate , compared with a response of only 17 % in patients receiving no metronidazole .
C1136254
antimicrobial
C0025872
metronidazole